// App-Quantinova.ai

OR13-5 : Vitamin-D Supplementation in Prediabetes Reduced Progression to type2 Diabetes through Decreased Insulin Resistance and Systemic Inflammation: An Open Label Randomized Prospective Study from Eastern India

Researchers

Presenter

  • Deep Dutta

Principal Investigators

  • Samim Ali Mondal

  • Indira Maisnam

  • Satinath Mukhopadhyay

  • Subhankar Chowdhury

Medical Centers

  • Institute of Post Graduate Medical Education & Research (IPGMER) and Seth Sukhlal Karnani Memorial (SSKM) Hospital, Calcutta, West Bengal, India

  • Institute of Post Graduate Medical Education & Research (IPGMER) and Seth Sukhlal Karnani Memorial (SSKM) Hospital, Calcutta, West Bengal, India

  • Institute of Post Graduate Medical Education & Research (IPGMER) and Seth Sukhlal Karnani Memorial (SSKM) Hospital, Calcutta, West Bengal, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Prediabetes

  • Systemic inflammation

  • Vitamin D deficiency

  • Hypertension

  • Diabetes

  • Type 2 diabetes mellitus

Biomarkers

  • High sensitivity C-reactive protein

  • Insulin

  • Interferon-gamma

  • Interleukin 6

  • Tumor necrosis factor

  • Body mass index

Drug/Treatment

  • cholecalciferol

  • ILS-969

  • Interleukin

  • Ergocalciferol

  • MK8970

Outcome

  • N/A

Study Design

  • open label

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved